Risk and outcomes of aortic valve endocarditis among patients with bicuspid and tricuspid aortic valves

Objective Patients with structural abnormalities of cardiac valves, including bicuspid aortic valve (BAV), are said to be at higher risk of infective endocarditis (IE). We sought to determine the risk of IE of the BAV compared with the tricuspid aortic valve (TAV) and to determine the risk of aortic valve replacement and mortality after IE. Methods From medical records of two US and one Italian hospitals, patients with their first episode of IE of any native valve were identified. In the US cohort 42 patients with BAV and 393 patients with TAV with IE occurring between 1 January 2000 and 30 June 2014 were identified. In the Italian cohort 48 patients with BAV and 341 patients with TAV with IE underwent valve replacement surgery between 1 January 2000 and1 November 2015. The risk of IE for BAV and TAV and subsequent outcomes were determined after matching to patients without IE. Results After adjustment for risk factors, the risk of IE in the US cohort was 23.1 (95% CI 8.1 to 100, p <0.0001) times greater for BAV than TAV. Patients with BAV with IE were more likely to have an aortic root abscess. Within the subsequent 5 years, BAV patients with IE were more likely to undergo valve replacement (85%) than TAV patients with IE (46%). Patients with IE were at increased risk of death. The findings were similar in the Italian cohort. Conclusions Patients with BAV are at markedly increased risk of IE and aortic root abscess than patients with TAV. Increased risk of IE in patients with BAV indicates they may be a candidate group for long-term trials of antibiotic prophylaxis of IE.

[1]  L. Baddour,et al.  Incidence of Infective Endocarditis in Patients With Bicuspid Aortic Valves in the Community. , 2016, Mayo Clinic proceedings.

[2]  J. Wasey.  Tools for Working with ICD-9 Codes, and Finding Comorbidities , 2015 .

[3]  B. Prendergast,et al.  Infective endocarditis and antibiotic prophylaxis – Authors' reply , 2015, The Lancet.

[4]  F. Chirillo,et al.  Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci. , 2015, International journal of cardiology.

[5]  E. Athan,et al.  Evolving epidemiology of injecting drug use-associated infective endocarditis: A regional centre experience. , 2015, Drug and alcohol review.

[6]  Y. Chua,et al.  Surgical management of infective endocarditis: an analysis of early and late outcomes. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  B. Hoen,et al.  Prophylaxis for infective endocarditis: let's end the debate , 2015, The Lancet.

[8]  B. Prendergast,et al.  Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis , 2015, BDJ.

[9]  Vivian S. Gainer,et al.  Evaluation of matched control algorithms in EHR-based phenotyping studies: A case study of inflammatory bowel disease comorbidities , 2014, J. Biomed. Informatics.

[10]  J. Pu,et al.  Changing profile of infective endocarditis: a clinicopathologic study of 220 patients in a single medical center from 1998 through 2009. , 2014, Texas Heart Institute journal.

[11]  Y. Bossé,et al.  A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). , 2014, Journal of the American College of Cardiology.

[12]  J. Miro,et al.  Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. , 2014, International journal of cardiology.

[13]  Y. Bossé,et al.  Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). , 2014, Circulation.

[14]  H. Krumholz,et al.  Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. , 2013, Journal of the American College of Cardiology.

[15]  L. Burrell,et al.  Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis. , 2013, International journal of cardiology.

[16]  Y. Kokubo,et al.  Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. , 2013, International journal of cardiology.

[17]  L. Schwamm,et al.  Comparison of Ischemic Stroke Outcomes and Patient and Hospital Characteristics by Race/Ethnicity and Socioeconomic Status , 2013, Stroke.

[18]  V. Rousson,et al.  Use of a Human-Like Low-Grade Bacteremia Model of Experimental Endocarditis To Study the Role of Staphylococcus aureus Adhesins and Platelet Aggregation in Early Endocarditis , 2012, Infection and Immunity.

[19]  A. Bottle,et al.  Systematic Review of Comorbidity Indices for Administrative Data , 2012, Medical care.

[20]  D. Raoult,et al.  Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study , 2010, Heart.

[21]  P. Austin,et al.  A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data , 2009, Medical care.

[22]  Andrew Wang,et al.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.

[23]  F. Bayrak,et al.  Impact of bicuspid aortic valve on complications and death in infective endocarditis of native aortic valves. , 2009, Texas Heart Institute journal.

[24]  D. Richards.  Prophylaxis against infective endocarditis , 2008, Evidence-Based Dentistry.

[25]  A. D. Diez Roux,et al.  Area socioeconomic status and mortality after coronary artery bypass graft surgery: the role of hospital volume. , 2007, American heart journal.

[26]  Larry M Baddour,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card , 2007, Circulation.

[27]  杜昕,et al.  Infective endocarditis , 2007 .

[28]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Eykyn,et al.  Bicuspid aortic valve--A silent danger: analysis of 50 cases of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[31]  S. Shafran,et al.  Infective endocarditis: review of 135 cases over 9 years. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  L. Cohn,et al.  Determinants of early mortality and late survival in mitral valve endocarditis. , 1995, Circulation.

[33]  R. Sapru,et al.  Active infective endocarditis observed in an Indian hospital 1981-1991. , 1992, The American journal of cardiology.

[34]  M. Terpenning.  Infective endocarditis. , 1992, Clinics in geriatric medicine.

[35]  S. Rogers,et al.  Prevention of infective endocarditis' , 1988, British Dental Journal.